PRJNA207719: Tissue specific transcriptome profiling
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
mef2ca | dr11_v1_chr10_-_43568239_43568241 | 0.83 | 8.1e-02 | Click! |
mef2cb | dr11_v1_chr5_-_48307804_48307804 | 0.51 | 3.8e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_11201096 Show fit | 4.69 |
ENSDART00000171916
ENSDART00000171521 ENSDART00000087105 ENSDART00000159603 |
myomesin 2a |
|
chr5_+_51597677 Show fit | 3.28 |
ENSDART00000048210
ENSDART00000184797 |
creatine kinase, mitochondrial 2b (sarcomeric) |
|
chr11_+_11200550 Show fit | 3.22 |
ENSDART00000181339
ENSDART00000187116 |
myomesin 2a |
|
chr8_-_26388090 Show fit | 3.01 |
ENSDART00000147912
|
si:dkey-20d21.12 |
|
chr25_+_29160102 Show fit | 2.78 |
ENSDART00000162854
|
pyruvate kinase M1/2b |
|
chr9_-_42873700 Show fit | 2.73 |
ENSDART00000125953
|
titin, tandem duplicate 1 |
|
chr12_-_26064480 Show fit | 2.68 |
ENSDART00000158215
ENSDART00000171206 ENSDART00000171212 ENSDART00000182956 ENSDART00000186779 |
LIM domain binding 3b |
|
chr12_-_26064105 Show fit | 2.66 |
ENSDART00000168825
|
LIM domain binding 3b |
|
chr16_+_25245857 Show fit | 2.62 |
ENSDART00000155220
|
kelch-like family member 38b |
|
chr11_-_18253111 Show fit | 2.53 |
ENSDART00000125984
|
musculoskeletal, embryonic nuclear protein 1b |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 12.8 | GO:0006936 | muscle contraction(GO:0006936) |
0.0 | 10.1 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.0 | 6.2 | GO:0061061 | muscle structure development(GO:0061061) |
0.1 | 4.6 | GO:0050821 | protein stabilization(GO:0050821) |
0.3 | 4.3 | GO:0006599 | phosphagen metabolic process(GO:0006599) phosphocreatine metabolic process(GO:0006603) phosphagen biosynthetic process(GO:0042396) phosphocreatine biosynthetic process(GO:0046314) |
0.2 | 4.3 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.0 | 3.4 | GO:0030239 | myofibril assembly(GO:0030239) |
0.3 | 2.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 2.9 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.2 | 2.8 | GO:0034629 | cellular protein complex localization(GO:0034629) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 17.8 | GO:0031430 | M band(GO:0031430) |
0.2 | 17.2 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 6.2 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 6.1 | GO:0005865 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.1 | 4.6 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 3.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 2.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 2.4 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 2.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 1.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 21.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.4 | 7.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) alpha-actinin binding(GO:0051393) |
0.0 | 6.2 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.2 | 5.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 4.3 | GO:0016775 | creatine kinase activity(GO:0004111) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.1 | 3.9 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.0 | 3.7 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 3.5 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 3.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.5 | 2.8 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 1.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 1.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 1.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.5 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 2.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 1.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 1.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.6 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |